Full text
PDFPage 1267
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bakimer R., Fishman P., Blank M., Sredni B., Djaldetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest. 1992 May;89(5):1558–1563. doi: 10.1172/JCI115749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chaouat G., Menu E., Clark D. A., Dy M., Minkowski M., Wegmann T. G. Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy. J Reprod Fertil. 1990 Jul;89(2):447–458. doi: 10.1530/jrf.0.0890447. [DOI] [PubMed] [Google Scholar]
- Cowchock F. S., Reece E. A., Balaban D., Branch D. W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992 May;166(5):1318–1323. doi: 10.1016/0002-9378(92)91596-3. [DOI] [PubMed] [Google Scholar]
- Fishman P., Bakimer R., Blank M., Sredni D., Djaldetti M., Shoenfeld Y. The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice. Clin Exp Immunol. 1992 Nov;90(2):266–270. doi: 10.1111/j.1365-2249.1992.tb07940.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fishman P., Falach-Vaknine E., Zigelman R., Bakimer R., Sredni B., Djaldetti M., Shoenfeld Y. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest. 1993 Apr;91(4):1834–1837. doi: 10.1172/JCI116396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gharavi A. E., Sammaritano L. R., Wen J., Elkon K. B. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J Clin Invest. 1992 Sep;90(3):1105–1109. doi: 10.1172/JCI115927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lockshin M. D., Letendre C. H. Antiphospholipid antibody/lupus anticoagulant workshop. Arthritis Rheum. 1992 Oct;35(10):1234–1237. doi: 10.1002/art.1780351017. [DOI] [PubMed] [Google Scholar]
- Out H. J., Kooijman C. D., Bruinse H. W., Derksen R. H. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol. 1991 Oct 8;41(3):179–186. doi: 10.1016/0028-2243(91)90021-c. [DOI] [PubMed] [Google Scholar]
- Rustin M. H., Bull H. A., Machin S. J., Isenberg D. A., Snaith M. L., Dowd P. M. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol. 1988 May;90(5):744–748. doi: 10.1111/1523-1747.ep12560947. [DOI] [PubMed] [Google Scholar]
- Sammaritano L. R., Gharavi A. E., Soberano C., Levy R. A., Lockshin M. D. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J Clin Immunol. 1992 Jan;12(1):27–35. doi: 10.1007/BF00918270. [DOI] [PubMed] [Google Scholar]
- Shoenfeld Y. Induction of experimental primary and secondary antiphospholipid syndromes in naive mice. Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):219–221. doi: 10.1111/j.1600-0897.1992.tb00796.x. [DOI] [PubMed] [Google Scholar]